Evidence map›Paper›PMID 34397088›Full record

ArticleDevelopment (Cambridge, England)2021

The combined action of Esrrb and Nr5a2 is essential for murine naïve pluripotency.

Nicola Festuccia, Nick Owens, Almira Chervova, Agnès Dubois, Pablo Navarro

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nicola FestucciaRegulatory Dynamics and Cell Identity, MRC London Institute of Medical Sciences (LMS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.ORCID 0000-0001-5962-8263
Nick OwensInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK.ORCID 0000-0002-2151-9923
Almira ChervovaEpigenomics, Proliferation, and the Identity of Cells, Department of Developmental and Stem Cell Biology, Institut Pasteur, CNRS UMR3738, 75015 Paris, France.
Agnès DuboisEpigenomics, Proliferation, and the Identity of Cells, Department of Developmental and Stem Cell Biology, Institut Pasteur, CNRS UMR3738, 75015 Paris, France.
Pablo NavarroEpigenomics, Proliferation, and the Identity of Cells, Department of Developmental and Stem Cell Biology, Institut Pasteur, CNRS UMR3738, 75015 Paris, France.ORCID 0000-0002-2700-6598
Centre National de la Recherche Scientifique · FRUniversity of Exeter · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

The maintenance of pluripotency in mouse embryonic stem cells (ESCs) is governed by the action of an interconnected network of transcription factors. Among them, only Oct4 and Sox2 have been shown to be strictly required for the self-renewal of ESCs and pluripotency, particularly in culture conditions in which differentiation cues are chemically inhibited. Here, we report that the conjunct activity of two orphan nuclear receptors, Esrrb and Nr5a2, parallels the importance of that of Oct4 and Sox2 in naïve mouse ESCs. By occupying a large common set of regulatory elements, these two factors control the binding of Oct4, Sox2 and Nanog to DNA. Consequently, in their absence the pluripotency network collapses and the transcriptome is substantially deregulated, leading to the differentiation of ESCs. Altogether, this work identifies orphan nuclear receptors, previously thought to be performing supportive functions, as a set of core regulators of naïve pluripotency.

Indexed as

AnimalsCell DifferentiationCell Self RenewalGene Regulatory NetworksMiceMouse Embryonic Stem CellsNanog Homeobox ProteinOctamer Transcription Factor-3Protein BindingReceptors, Cytoplasmic and NuclearReceptors, EstrogenSOXB1 Transcription FactorsEsrrb protein, mouseNanog Homeobox ProteinNanog protein, mouseNr5a2 protein, mouseOctamer Transcription Factor-3Pou5f1 protein, mouseReceptors, Cytoplasmic and NuclearReceptors, EstrogenSox2 protein, mouseSOXB1 Transcription FactorsEmbryonic stem cellsEsrrbNr5a2Orphan nuclear receptorsPluripotency

Identifiers

PMID34397088
PMCPMC8451941
OpenAlexW3195963110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.